Tertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06883565

Enrollment

232

Registered

2025-03-19

Start date

2024-06-01

Completion date

2025-01-31

Last updated

2025-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Cell Carcinoma (RCC)

Brief summary

The purpose of this research was to uncover the prognostic significance of tertiary lymphoid structures related genes from ccRCC patients with respect to clinical characteristics and outcomes. This offers a novel perspective on selecting populations for prostate cancer immunotherapy in future scenarios.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Inclusion criteria

* patients diagnosed with renal cell carcinoma

Exclusion criteria

* incomplete medical records, inadequate follow-up information, and confirmed non-prostatic acinar adenocarcinoma

Design outcomes

Primary

Measure	Time frame
Correlation between the high or low score of TLS(tertiary lymphoid structure) related gene model and clinical features	1 month

Countries

China

Outcome results